Category: Pharmaceuticals
Atara Biotherapeutics, the California-based allogeneic T-cell immunotherapy company, that is known for developing original treatments for patients suffering from cancer, viral and autoimmune diseases, recently announced that its collaborators …
AstraZeneca will fund the transaction partly from the proceeds of a new equity placement of up to $3.5 billion. AstraZeneca Plc has agreed to pay up to $6.9 billion …
NASH is a complex medical condition for which multimodal treatments are required to treat the complete range of patients DURECT Corporation has reportedly announced that it has started the …
Mayzent is anticipated to be launched in the United States in about a week Novartis AG has reportedly gained approval from the US FDA (Food & Drug Administration) for …
Menlo Therapeutics has reportedly got its Phase 2 clinical trial data pertaining to the use of serlopitant to treat pruritus linked to prurigo nodularis (PN) published in the Journal …
Ascendis Pharma, a renowned biopharmaceutical firm which utilizes its state-of-the-art TransCon technology to deal with unmet therapeutic needs, has recently declared top-line outcomes from its main phase III heiGHt …
Biogen Inc., the U.S.-based biotechnology industry major, has apparently halted two significant Phase 3 trials intended for testing the Alzheimer’s drug Aducanumab, which has recently delivered sheer disappointment to …
The pre-clinical trials of saracatinib exhibited that it hinders collagen deposition and fibroblast activity, which are crucial aspects of lung fibrosis Saracatinib has completed Phase I development The United …
The company’s RP-L102 could offer a potentially curative therapeutic option for FA patients The treatment is already under Phase 1 and 2 clinical trials in the European Union Rocket …
The new joint venture will be dedicated towards the research and development of cannabinoid formulations for treating ophthalmic disorders and address significant unmet medical needs in the market A …
